Envoy Medical, Inc. financial data

Symbol
COCH, COCHW on Nasdaq
Location
White Bear Lake, MN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 95% % 9.1%
Quick Ratio 21% % 6%
Debt-to-equity -149% % 18%
Return On Equity 108% % -48%
Return On Assets -218% % 15%
Operating Margin -9824% % -27%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28,786,511 shares 42%
Common Stock, Shares, Outstanding 21,520,932 shares 16%
Entity Public Float $16,700,000 USD -62%
Common Stock, Value, Issued $2,000 USD
Weighted Average Number of Shares Outstanding, Basic 21,851,606 shares 17%
Weighted Average Number of Shares Outstanding, Diluted 21,851,606 shares 17%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $208,000 USD -25%
Cost of Revenue $226,000 USD 48%
Research and Development Expense $10,404,000 USD -3.1%
Selling and Marketing Expense $1,642,000 USD -5%
General and Administrative Expense $7,775,000 USD -7.4%
Costs and Expenses $20,641,000 USD -4.9%
Operating Income (Loss) $20,433,000 USD 4.7%
Nonoperating Income (Expense) $1,355,000 USD -606%
Net Income (Loss) Attributable to Parent $21,788,000 USD -3.4%
Earnings Per Share, Basic -1 USD/shares -19%
Earnings Per Share, Diluted -1 USD/shares -19%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $35,000 USD -82%
Inventory, Net $1,639,000 USD -0.12%
Assets, Current $5,757,000 USD -19%
Property, Plant and Equipment, Net $1,116,000 USD -6.8%
Assets $8,181,000 USD -13%
Accounts Payable, Current $2,681,000 USD 53%
Accrued Liabilities, Current $5,864,000 USD -14%
Liabilities, Current $8,988,000 USD -0.95%
Other Liabilities, Noncurrent $891,000 USD
Liabilities $15,712,000 USD -44%
Accumulated Other Comprehensive Income (Loss), Net of Tax $120,000 USD 0.83%
Retained Earnings (Accumulated Deficit) $305,659,000 USD -10%
Stockholders' Equity Attributable to Parent $7,661,000 USD 59%
Liabilities and Equity $8,181,000 USD -13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,725,000 USD 33%
Net Cash Provided by (Used in) Financing Activities $3,554,000 USD -45%
Net Cash Provided by (Used in) Investing Activities $6,000 USD 94%
Common Stock, Shares Authorized 400,000,000 shares
Common Stock, Shares, Issued 21,520,932 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $171,000 USD -124%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,556,000 USD -20%
Interest Paid, Excluding Capitalized Interest, Operating Activities $13,000 USD -7.1%
Deferred Tax Assets, Valuation Allowance $52,779,000 USD 5.1%
Deferred Tax Assets, Gross $53,212,000 USD 5%
Operating Lease, Liability $923,000 USD 73%
Depreciation $76,000 USD 55%
Payments to Acquire Property, Plant, and Equipment $6,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $21,787,000 USD -2.9%
Lessee, Operating Lease, Liability, to be Paid $1,182,000 USD 118%
Property, Plant and Equipment, Gross $6,168,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $230,000 USD 48%
Lessee, Operating Lease, Liability, to be Paid, Year One $223,000 USD 45%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $259,000 USD 3138%
Lessee, Operating Lease, Liability, to be Paid, Year Three $195,000 USD 97%
Deferred Tax Assets, Operating Loss Carryforwards $43,283,000 USD 5.2%
Preferred Stock, Shares Issued 4,126,667 shares -96%
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $198,000 USD
Operating Lease, Payments $50,000 USD
Additional Paid in Capital $298,116,000 USD 15%
Preferred Stock, Shares Outstanding 4,126,667 shares
Deferred Tax Assets, Net of Valuation Allowance $433,000 USD -1.1%
Share-based Payment Arrangement, Expense $160,000 USD 30%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%